Oakp-11
Autoimmune diseases; neuropathic pain
Phase 1Active
Key Facts
About Akaal Pharma
Australian biotech developing selective S1P1 modulators for dermatology and autoimmune indications.
View full company profileAutoimmune diseases; neuropathic pain
Australian biotech developing selective S1P1 modulators for dermatology and autoimmune indications.
View full company profile